Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 459 of 1,261
  1. US 10485869

    Etanercept formulations stabilized with meglumine

    Coherus BioSciences, Inc. · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  2. US 10485841

    Method for producing dry extracts

    BIONORICA SE · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  3. US 10485809

    Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  4. US 10485803

    Pyrimidine compounds as JAK kinase inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  5. US 10485800

    Mixed lineage kinase inhibitors for HIV/AIDS therapies

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  6. US 10485796

    LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

    Biomed Valley Discoveries, Inc. · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  7. US 10485782

    Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

    Amazentis SA · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  8. US 10485766

    Drug delivery system and method for the treatment of neuro-degenerative disease

    Aphios Corporation · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  9. US 10485771

    Methods of regulating cannabinoid receptor activity-related disorders and diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted
  10. CA 3099620

    DOSE INITIALE DE CONJUGUES DE LA PTH

    ASCENDIS PHARMA BONE DISEASES AS [DK] · Granted Nov 21, 2019 · Expires Nov 16, 2039

    granted
  11. US 10478487

    Foot-and-mouth disease vaccine

    United States of America as represented by the Secretary of the Air Force · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted
  12. US 10478430

    Compounds useful as inhibitors of ATR kinase and combination therapies thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted
  13. US 10479786

    Protein kinase inhibitors

    Princeton Drug Discovery, Inc · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted
  14. US 10479996

    Antisense antiviral compound and method for treating ss/RNA viral infection

    Sarepta Therapeutics, Inc. · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted
  15. BR PI0923819

    compostos farmacêuticos

    BIAL PORTELA & Cª S A [PT] · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted
  16. US 10478415

    Ketone bodies to protect tissues from damage by ionizing radiation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted
  17. US 10478449

    2′-methoxy substituted oligomeric compounds and compositions for use in gene modulations

    Ionis Pharmaceuticals, Inc. · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted
  18. US 10478206

    Instruments and methods for the implantation of cell-seeded substrates

    The Regents of the University of California · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted
  19. US 10478396

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted
  20. US 10478410

    Process to prepare treprostinil, the active ingredient in Remodulin®

    United Therapeutics Corporation · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted
  21. US 10478385

    Dental adhesive material kit

    KURARAY NORITAKE DENTAL INC. · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted
  22. US 10478404

    Materials, methods and devices for altering cell reactivity

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted
  23. US 10478409

    Pharmaceutical compositions

    KalVista Pharmaceuticals Limited · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted
  24. US 10478448

    Methods and compositions for modulating apolipoprotein (a) expression

    Ionis Pharmaceuticals, Inc. · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.